1. Home
  2. CHEF vs RCUS Comparison

CHEF vs RCUS Comparison

Compare CHEF & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Chefs' Warehouse Inc.

CHEF

The Chefs' Warehouse Inc.

HOLD

Current Price

$59.97

Market Cap

2.5B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.17

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHEF
RCUS
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
CHEF
RCUS
Price
$59.97
$23.17
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$71.88
$29.38
AVG Volume (30 Days)
351.5K
2.0M
Earning Date
02-11-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
55.09
N/A
EPS
1.73
N/A
Revenue
$4,040,541,000.00
$240,000,000.00
Revenue This Year
$10.35
N/A
Revenue Next Year
$7.09
N/A
P/E Ratio
$35.18
N/A
Revenue Growth
8.88
N/A
52 Week Low
$45.00
$6.50
52 Week High
$68.94
$26.40

Technical Indicators

Market Signals
Indicator
CHEF
RCUS
Relative Strength Index (RSI) 38.72 52.69
Support Level $59.78 $20.59
Resistance Level $63.54 $24.16
Average True Range (ATR) 1.53 1.08
MACD -0.48 -0.18
Stochastic Oscillator 3.20 72.37

Price Performance

Historical Comparison
CHEF
RCUS

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: